Chai Discovery

Chai Discovery specializes in developing advanced AI foundation models designed to predict and reprogram interactions between biochemical molecules, the essential components of life. The company operates in the biotechnology and pharmaceutical sectors, serving clients ranging from academic researchers to pharmaceutical companies. Chai Discovery's core product, Chai 1, is a state-of-the-art multimodal foundation model that excels in predicting molecular structures, including proteins, small molecules, DNA, RNA, and covalent modifications. The model is accessible for free via a web interface, making it available for both academic and commercial applications, particularly in drug discovery. The business model primarily revolves around providing this AI-driven platform to clients who can leverage it to accelerate their research and development processes. Revenue is generated through commercial licensing agreements and partnerships with pharmaceutical companies.

Keywords: AI, biochemical molecules, drug discovery, molecular research, foundation models, proteins, DNA, RNA, covalent modifications, biotechnology.